Q3 2023 · 13F-HR
Velan Capital Investment Management LPholdings as filed
Filed 2023-11-13 · accession 0001848809-23-000004
$124.0M
Reported value
29
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 016259202 | — | ALIMERA SCIENCES INC | $42.2M | 34.0% | 13,608,533 | Common | SOLE |
| 74006W108 | — | PRAXIS PRECISION MEDICINES I | $8.9M | 7.15% | 5,185,000 | Common | SOLE |
| 471871103 | — | JASPER THERAPEUTICS INC | $7.6M | 6.12% | 11,219,036 | Common | SOLE |
| 427746102 | HRTX | HERON THERAPEUTICS INC | $7.2M | 5.80% | 6,986,744 | Common | SOLE |
| 000899104 | ADMA | ADMA BIOLOGICS INC | $6.2M | 5.01% | 1,736,100 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $6.0M | 4.81% | 746,087 | Common | SOLE |
| 74880P104 | QIPT | QUIPT HOME MEDICAL CORP | $5.6M | 4.52% | 1,100,000 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $5.2M | 4.20% | 75,000 | Common | SOLE |
| 68404V100 | — | OPTINOSE INC | $4.4M | 3.57% | 3,596,861 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $3.2M | 2.54% | 55,300 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $3.0M | 2.45% | 15,300 | Common | SOLE |
| 45253H101 | IMGNEUR | IMMUNOGEN INC | $3.0M | 2.43% | 189,500 | Common | SOLE |
| 45779A846 | NSPR | INSPIREMD INC | $3.0M | 2.38% | 904,029 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $2.6M | 2.06% | 3,065,136 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $2.3M | 1.84% | 150,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $1.9M | 1.53% | 50,000 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $1.7M | 1.33% | 778,500 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $1.6M | 1.33% | 24,937 | Common | SOLE |
| 45114M109 | — | ICOSAVAX INC | $1.2M | 1.00% | 160,630 | Common | SOLE |
| 04522R200 | — | ASLAN PHARMACEUTICALS LTD | $1.2M | 0.95% | 625,000 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $1.1M | 0.92% | 250,000 | CALL | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $1.1M | 0.88% | 459,746 | Common | SOLE |
| 27966L108 | — | EDESA BIOTECH INC | $809,981 | 0.65% | 1,281,615 | Common | SOLE |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $678,750 | 0.55% | 75,000 | Common | SOLE |
| N44821101 | IFRX | INFLARX NV | $596,000 | 0.48% | 200,000 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $528,000 | 0.43% | 400,000 | Common | SOLE |
| 74880P104 | QIPT | QUIPT HOME MEDICAL CORP | $509,000 | 0.41% | 100,000 | CALL | SOLE |
| 45720L107 | INBXUSD | INHIBRX INC | $458,750 | 0.37% | 25,000 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $329,510 | 0.27% | 497,299 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.